A total of 1.3 million people died from TB in 2022 (including 167 000 people with HIV). Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS). In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, of which almost 3 million people with active TB remained undetected, hence untreated.

Systematic screening for active TB with prompt and accurate diagnosis followed by the provision of treatment prevents deaths and limits ill health among people who develop TB. It also prevents further transmission of infection to others. Screening for active TB is recommended for vulnerable populations, and for many countries a priority to increase case notification rates to 90+%, as illustrated below. The use of ultra-portable X-ray systems/PDX with CAD presents an opportunity to improve the detection of TB also in hard-to-reach key populations.

Treatment coverage vs. Treatment success